Understanding patient views on labeling and reporting for low-grade prostate cancer
Patient Perspectives on Relabeling and Pathology Reporting for Grade Group 1 Prostate Cancer
This study is looking to understand how people with low-grade prostate cancer feel about the word 'cancer' and how they prefer their pathology reports to be presented, so we can make sure everyone, including Spanish speakers, gets the information in a way that feels right for them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11049000 on NIH RePORTER |
What this research studies
This research investigates how patients perceive the term 'cancer' in relation to low-grade prostate cancer, which often has a slow progression. It aims to gather insights from diverse patient populations about their preferences for pathology report presentations. The study will involve qualitative interviews, discrete choice experiments, and a randomized trial to evaluate different wording in pathology reports. The research will be conducted in both English and Spanish to ensure inclusivity.
Who could benefit from this research
Good fit: Ideal candidates for this research include men diagnosed with Grade Group 1 prostate cancer, particularly from diverse backgrounds including Black and Hispanic populations.
Not a fit: Patients with high-grade prostate cancer or those not diagnosed with prostate cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more patient-friendly communication regarding low-grade prostate cancer, potentially reducing anxiety and improving patient understanding.
How similar studies have performed: While there is ongoing debate about cancer nomenclature, this specific approach to understanding patient perspectives is relatively novel and has not been extensively tested.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Ramirez-Valles, Jesus — University of California, San Francisco
- Study coordinator: Ramirez-Valles, Jesus
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.